Ludwig Burger
@LudwigBurger
Followers
308
Following
24
Media
2
Statuses
122
Senior Correspondent at Thomson Reuters - views expressed are my own
Joined December 2010
The chemical industry’s path toward sustainability was never going to linear. @UmicoreGroup #EVs
https://t.co/PILwpou1p9
0
1
1
It's early days for the science underpinning any use of #cgm in endurance sports. More to geek out on here: #continuousglucosemonitoring #glucose
https://t.co/vluhQPbCpZ
reuters.com
Some Olympic athletes are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.
1
0
2
Medical diagnostic tech is making the leap to elite sports. With @Sripootweets #cgm #continuousglucosemonitoring #glucose
https://t.co/AsLxYgFkN4
reuters.com
Olympians including Dutch marathon runner Abdi Nageeye are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.
0
1
1
It would be a cash call for all the wrong reasons, but some sell-side and buy-side analysts are giving serious thought to that scenario at embattled #Bayer. With @EmmaVictoriaF and Patricia Weiss https://t.co/Typ8xJ9TNz
0
0
0
This is a great story - not because of any narrative but because of what happened. https://t.co/L6s9Ybp4eN
reuters.com
Hungarian scientist Katalin Kariko and U.S. colleague Drew Weissman, who met in line for a photocopier before making mRNA molecule discoveries that paved the way for COVID-19 vaccines, won the 2023...
0
0
0
New #Bayer CEO Bill Anderson is walking the talk about too much red tape at the German healthcare and agriculture company. But that should only be a step on the way to bigger changes. https://t.co/N9dE98Lpi1
reuters.com
Bayer's new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group, which is facing investor pressure to break up, three people...
0
0
1
Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters.
reuters.com
Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters.
0
1
0
In the words of Emily Field and team @BarclaysCIB "If they play baseball in Denmark, #Wegovy just hit a home run" https://t.co/Npeva6rKEP
reuters.com
Wegovy maker Novo Nordisk said on Tuesday a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving beyond...
0
0
0
A debate to follow when #Wegovy comes to market in Germany this month: Will there be, at some point, any change in drug coverage policies that some say reflects a stigmatisation of obesity? https://t.co/fsbvhZ6aYM
reuters.com
Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica Lenth from Hamburg has started putting money aside for a drug that she sees as a possible door to a life without...
0
0
1
#NovoNordisk's #Wegovy is coming to self-payer market Germany for a little over €300 per month. Overwhelmed by demand elsewhere, the company is already pleading for restraint with German doctors. https://t.co/NkkiJiDcC5
reuters.com
Novo Nordisk on Friday urged doctors in Germany to limit prescriptions of its popular Wegovy weight-loss drug to patients with medical needs, citing limited supplies as the company prepares to launch...
0
0
2
German hidden champion Freiberger Compound Materials consumes about 10% of the global #gallium production. It is for now relatively relaxed about Chinese export controls but its clients clearly are not. https://t.co/FvJDpYvxVC
reuters.com
China's planned export controls on gallium have caused frantic stockpiling of speciality semiconductor wafers made from the metal, according to the world's largest gallium buyer.
0
0
1
Europe's public-health policy makers are largely immune to the hype over new #obesity drugs. Case in point: Germany is developing a disease management programme for obesity but a no-reimbursement rule for weight-loss drugs will not be touched. https://t.co/6IWMht4qxe
reuters.com
Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health...
0
0
1
Sanofi, one of the largest influenza vaccines suppliers, says the industry's current generation of mRNA flu vaccine candidates will not be up to the task. Will we hear Pfizer, BioNTech and Moderna say 'speak for yourself' ? https://t.co/XG22IlnUMY
reuters.com
Sanofi said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and it is already working on a next generation...
0
0
2
#BlueRock, acquired by #Bayer in 2019, is making early progress on #parkinsons #parkinsonsdisease stem cell therapy development. A crowded field of research teams around the globe is pursuing this complex technology. https://t.co/egVRre9dea
reuters.com
Bayer subsidiary BlueRock has become the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy, the drugmaker said on Wednesday.
0
1
0
I personally don't mind if pharmaceutical companies make a lot of money out of those drugs if they delivered. For Big Pharma haters, there's still the consolation that there would be far less money to be made out of diabetes type 2, hypertension, statins and whatnot drugs. 2/
5
7
107
"Investors love simple structures, with a clear focus on the core business. This is the case everywhere, not only in Germany," @JoeKaeser tells us. He should know. @Siemens_Energy @Siemens @LudwigBurger
reuters.com
Brenntag, Bayer, Fresenius in the crosshairs of activist investors.
0
1
2
The UK's recent disastrous "mini" Budget can trace its origins back to Britain's decision to leave the European Union. The economic costs of Brexit were masked by the pandemic and the Ukraine crisis. But six years after the vote, the Brexit effect is clear
206
2K
4K
Merck KGaA's (@merckgroup) Belen Garijo sits down with @Reuters correspondent @LudwigBurger to discuss key trends in drug development and global microchip production. Register for our #ReutersNEXT Newsmaker this Thursday at 11:00 a.m. GMT. https://t.co/2Tj9ouqRS8
0
1
1